Sabra Health Care REIT
SBRA Nasdaq· Health Care REITs
Last close · Oct 26, 2026
$19.78
KIRA · Stoqly’s AI analyst, in plain words
- Sabra Health Care REIT had $775M of revenue in fiscal 2025, up 10.2% on the year before. Over five years, revenue changed +5.3% a year on average.
- Sabra Health Care REIT made $156M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew −4.0% a year.
- Sabra Health Care REIT returned $290M to shareholders in fiscal 2025. The diluted share count rose 3.6%.
- Sabra Health Care REIT owes $2.5B more than it holds in cash, about 5.4 years of operating profit.
Market cap
$5.0B
P/E
76.1x
Revenue
$775M
Net income
$156M
Free cash flow
—
Operating margin
—
Sabra Health Care REIT in 30 seconds · fiscal 2025
Are sales growing?
+10.2%
Yes. Sales grew 10.2% last year.
Does it make a profit?
20.1%
Yes. It keeps 20.1% of every sale as profit.
Is debt under control?
5.4x
Heavy. Repaying its debt would take 5.4 years of operating profit.
How is the share priced?
76.1x
One share costs 76.1 times its yearly profit per share. Typical for its sector: 27.8x.
What Sabra Health Care REIT does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 12, 2026
- Legal name
- SABRA HEALTH CARE REIT, INC.
- CIK
- 0001492298
Sabra Health Care REIT · SBRA
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $570M | $625M | $648M | $703M | $775M |
| Revenue growth | −4.9% | 9.7% | 3.6% | 8.6% | 10.2% |
| Net income | −$113M | −$77.6M | $13.8M | $127M | $156M |
| Net margin | −19.9% | −12.4% | 2.1% | 18.0% | 20.1% |
| Diluted EPS | −$0.52 | −$0.34 | $0.06 | $0.54 | $0.64 |
| Cash | |||||
| Cash from operations | $356M | $316M | $301M | $311M | $349M |
| Dividends paid | $263M | $277M | $277M | $280M | $290M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share count change | 5.7% | 5.4% | 0.8% | 1.4% | 3.6% |
| Debt and strength | |||||
| Cash and short-term investments | $112M | $49.3M | $41.3M | $60.5M | $71.5M |
| Debt incl. finance leases | $2.4B | $2.5B | $2.4B | $2.4B | $2.5B |
| Shareholders' equity | $3.4B | $3.1B | $2.8B | $2.7B | $2.8B |
| Net debt / EBITDA | 6.4x | 7.8x | 7.5x | 5.7x | 5.4x |
| Interest coverage | 1.8x | 1.2x | 1.2x | 2.1x | 2.4x |
| Returns and quality | |||||
| Return on capital | 3.1% | 2.1% | 2.2% | 4.7% | 5.1% |
| Return on equity | −3.3% | −2.4% | 0.5% | 4.6% | 5.6% |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$4.5M
2 insiders
Of sales under plans
93%
$4.2M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Sabra Health Care REIT · SBRA
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| Sabra Health Care REIT SBRA | $5.0B | 10.2% | — | — | 5.1% | 76.1x | — |
| Healthcare Realty Trust HR | $6.2B | −6.9% | — | 10.8% | — | — | — |
| Omega Healthcare Investors OHI | $14.9B | 13.2% | — | 67.0% | 8.8% | 16.8x | — |
| CareTrust REIT CTRE | $8.7B | 60.8% | — | — | 9.3% | 23.1x | — |
| American Healthcare REIT AHR | $10.4B | 9.2% | 18.4% | — | — | 78.8x | — |
Price compared with profit (P/E)
How many times its yearly profit per share one share costs. Higher means investors pay more for each unit of profit.
KIRA
At $19.78 a share, the company is worth $5.0B: 76.1 times its earnings of the last four quarters.
Sabra Health Care REIT grew sales faster than 2 of its 4 similar companies. Its P/E is higher than 2 of 3.
Source: SEC EDGAR XBRL filings (CIK 0001492298). Data updated October 18, 2026. For information only — not investment advice. Check the original filings before relying on any figure.